Lung Transplant Infection Clinical Trial
Official title:
Evaluation of Tolsura When Used as Prophylaxis After Lung Transplantation
This is a single-center, observational study of Tolsura PK sampling in lung transplant recipients
Patients who are receiving Tolsura as part of their clinical care will be asked to enroll and EMR data and excess biological samples will be collected ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03112044 -
Lung Transplant HCV, Pilot Study
|
Early Phase 1 | |
| Terminated |
NCT03905447 -
The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients.
|
Phase 2 | |
| Completed |
NCT01952470 -
Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant.
|
Phase 2 | |
| Recruiting |
NCT05050955 -
AlloSure Lung Assessment and Metagenomics Outcomes Study
|
||
| Completed |
NCT01419678 -
Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients
|
N/A | |
| Completed |
NCT05721079 -
Extracorporeal Photopheresis (ECP) After Lung Transplantation
|
N/A | |
| Recruiting |
NCT05960383 -
Molecular vs Conventional Microbiologic Diagnosis for Infections in Lung Transplantation
|
||
| Completed |
NCT02351180 -
Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04017338 -
Transplantation Using Hepatitis C Positive Donors, A Safety Trial
|
Phase 3 | |
| Recruiting |
NCT03545919 -
Clinical Significance of Community-acquired Respiratory Virus Infection and Longitudinal Analysis of the Lung Microbiome in Lung Transplantation
|